Optimal dose for the efficacy of asenapine in patients with schizophrenia: Real-world data.
Takekita Y, Hiraoka S, Iwama Y, Matsui D, Aoki N, Ogata H, Funatsuki T, Shimizu T, Murase Y, Koshikawa Y, Kato M, Kinoshita T.
Takekita Y, et al. Among authors: iwama y.
Neuropsychopharmacol Rep. 2024 Mar;44(1):234-239. doi: 10.1002/npr2.12389. Epub 2023 Nov 5.
Neuropsychopharmacol Rep. 2024.
PMID: 37926930
Free PMC article.